Polypharmacy in Osteoporosis Treatment

By sjmartinez • October 12, 2022

McConnell M, Shieh A. Polypharmacy in Osteoporosis Treatment. Clin Geriatr Med. 2022 Nov;38(4):715-726. doi: 10.1016/j.cger.2022.05.011. Epub 2022 Sep 13. PMID: 36210087.

Tags: Abaloparatide, Bisphosphonates, Denosumab, Endocrinology, Fractures, Osteoporosis, Polypharmacy, Publications, Romosozumab, Teriparatide

Regular Insulin Versus NPH Insulin for Continuous Enteral Tube Feeding in Hospitalized Patients

Kalangi ST, Bokka SM, Anand S, Garg R. Regular Insulin Versus NPH Insulin for Continuous Enteral Tube Feeding in Hospitalized Patients. Clin Diabetes. 2025 Apr[...]

Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program

Herman WH, Tyndall BD, Duru OK, Moin T, McEwen LN, Shao H, Ackermann RT, Jacobs SR, Neuwahl S, Kuo S, Zhang P, Pavkov ME, Villatoro[...]

Nardilysin in adipocyte regulates insulin sensitivity via HIF1alpha and PPARgamma

Matsuda S, Ohno M, Nishi K, Ikeda S, Iwasaki H, Eifuku T, Hiraoka Y, Kimura T, Ono K, Nishi E. Nardilysin in adipocyte regulates insulin[...]